NCT02425462View on ClinicalTrials.gov

To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With Endometriosis

CompletedOBSERVATIONAL

Enrollment

895

Participants

Timeline

Start Date

April 28, 2015

Primary Completion Date

September 28, 2018

Study Completion Date

December 14, 2018

Conditions

Endometriosis

Interventions

DRUG

Dienogest (Visanne, BAY86-5258)

Dienogest 2mg daily Oral dose

Trial Locations (6)

Unknown

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY